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Background: Despite strong research interest in psychosis risk identification and the potential for early intervention,
few papers have sought to document the implementation and evaluation of specialised psychosis related services.
Assessment of Ultra High Risk (UHR) has been given priority, but it is equally as important to identify appropriate
comparison groups and other baseline differences. This largely descriptive service evaluation paper focuses on the
‘baseline characteristics’ of referred clients (i.e., previously assessed characteristics or those identified within the first
two months following service presentation).
Methods: Data are reported from a 10-year layered service audit of all presentations to a ‘Psychological Assistance
Service’ for young people (PAS, Newcastle, Australia). Baseline socio-demographic and clinical characteristics (N =1,997)
are described (including clients’ psychosis and UHR status, previous service contacts, hospitalisation rates, and diagnostic
and comorbidity profiles). Key groups are identified and comparisons made between clients who received ongoing
treatment and those who were primarily assessed and referred elsewhere.
Results: Clients averaged 19.2 (SD =4.5) years of age and 59% were male. One-tenth of clients (9.6%) were categorised
as UHR, among whom there were relatively high rates of attenuated psychotic symptoms (69.1%), comorbid depression
(62.3%), anxiety (42.9%), and attentional and related problems (67.5%). Overall, one-fifth (19.8%) experienced a recent
psychotic episode, while a further 14.5% were categorised as having an existing psychosis (46.7% with a schizophrenia
diagnosis), amongst whom there were relatively high rates of comorbid substance misuse (52.9%), psychosocial (70.2%)
and physical health (37.7%) problems. The largest group presenting to PAS were those with non-psychotic disorders
(43.7%), who provide a valuable comparison group against which to contrast the health trajectories of those with UHR
and recent psychosis. Ongoing treatment by PAS was preferentially given to those experiencing or at risk for psychosis
and those reporting greater current distress or dysfunction.
Conclusions: Whether or not UHR clients transition to psychosis, they displayed high rates of comorbid depression and
anxiety at service presentation, with half receiving ongoing treatment from PAS. Although international comparisons
with similar services are difficult, the socio-demographic and comorbidity patterns observed here were viewed as largely
consistent with those reported elsewhere.
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Identification of psychosis risk
For the past 25 years psychosis research among young
people has tended to focus on identifying risk factors
and providing options for early intervention for individ-
uals in the initial stages of illness. The period to which
the term ‘Ultra High Risk’ (UHR) relates is between the
first noticeable changes in experience or behaviour and the
appearance of overt psychotic symptoms [1]. The existing
UHR criteria require that a young person (typically aged
14–30 years) who has been referred for mental health
(MH) problems meets one or more of the following cri-
teria: a) has experienced sub-threshold attenuated psych-
otic symptoms (APS); b) has experienced brief limited
intermittent psychotic symptoms (BLIPS) – that is, epi-
sodes of psychotic symptoms that have lasted less than a
week and resolved spontaneously; and/or c) meets trait
and state risk factor criteria – having a first degree relative
with a psychotic disorder or schizotypal personality dis-
order, whilst also experiencing a significant decline in func-
tioning during the previous year [1-4]. Similar UHR
criteria have been widely used throughout the world,
together with various terms such as ‘clinical high risk’, ‘at
risk mental state (ARMS)’, or ‘prodromal criteria’ [5,6]. As
these terms are reasonably interchangeable, for the pur-
poses of this paper, the term UHR will be used.
Potential benefits and shortcomings from identifying
psychosis risk status
While some centres and researchers have highlighted
the importance of assessing UHR status, in order to pro-
vide early intervention, recent studies have also indicated
that many individuals classified as UHR will not convert
to psychosis, and equally, those who are deemed not at
risk at the time of assessment may eventually develop
the disorder [7-9]. For example, these findings have
fuelled an ongoing debate in the Australian and New
Zealand Journal of Psychiatry around the issue of estab-
lishing psychosis risk and the provision of additional
early intervention services in Australia for people who
are either at risk or have recently experienced their first
episode [10-18].
Yung [12] defined early intervention as timely provision
of professional help to an individual with a first episode of
psychosis, arguing that much of the deterioration seen in
clients with schizophrenia and other psychotic disorders is
likely to be due to psychosocial factors that operate in the
first few years of illness (as opposed to inherent biological
processes). These factors include: disruption to education
and career trajectory; family stress or breakdown; loss
of friendships; depression; stigma; disruption of personal-
ity development; fear of relapse; substance misuse; home-
lessness; and post-traumatic stress disorder [12]. A recent
comprehensive review of the psychosis risk literature [6]reinforces this view, demonstrating that clients at risk
show psychopathologic, functional, neurocognitive and
structural abnormalities. Additionally, another recent re-
view of cognitive impairments and underlying patho-
physiology [19] suggests that the early signs of structural
and functional brain deficits among UHR clients are pre-
dictive of clinical outcomes. However, it is unclear to
what extent these findings reflect a range of psychiatric
disorders, psychological distress in general, or unique
features of psychosis; hence, more longitudinal research
is required comparing clients at risk who develop a
psychotic disorder with those who do not.
Tanskanen and colleagues [20] conducted a recent
qualitative study of help-seeking for a first psychosis epi-
sode, examining the perceptions of service users and
carers. Common alternative explanations for psychotic
symptoms included: substance misuse; stress; physical
illness; and other psychological conditions [20]. These
factors often add complexity to the clinical presentation
and to the provision of early intervention. Yung [12] ar-
gues that provision of early intervention can either pre-
vent these phenomena from occurring or minimise their
impact on the individual. In addition, McGorry provides
evidence from meta-analyses showing that early inter-
vention reduces the risk of transition to psychosis to less
than 10%, with psychological treatments such as cogni-
tive behaviour therapy being as effective as antipsychotic
medications [14,21].
A shorter duration of untreated psychosis (DUP) can
reduce the initial psychosocial damage and the risk of
traumatic forms of service entry and suicidal behaviours
[22,23]. However, evidence for the efficacy of public
health and educational campaigns in reducing DUP is
mixed [24,25]. Comparable initiatives in Australia [26]
and Canada [27] have not demonstrated the same bene-
fits and further fuelled the debate about early interven-
tion in psychosis. Castle [17] suggests that in Australia
there is no good evidence that intervening early has any
major effect on the longitudinal course of psychosis and
certainly cannot prevent schizophrenia. However, regard-
less of whether clients meet UHR criteria, or are treated
by specialist or generalist MH services, most are likely to
present with sufficiently serious MH conditions to war-
rant treatment [15].
Comorbidity considerations
There are high levels of comorbid drug and alcohol prob-
lems among individuals with schizophrenia and other
psychotic disorders [28-30], as well as comorbid depres-
sion, dysthymia, and anxiety disorders [31], contributing to
poorer global functioning and other negative outcomes
[28]. Both alcohol and cannabis abuse/dependence among
individuals with psychosis have been specifically associated
with male gender and younger age [28-30].
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to services who meet UHR criteria in fact present with
anxiety disorder or major depression [32-34]. Moreover,
psychotic like experiences have also been linked with trau-
matic stress disorders and substance use/dependence [35].
Similarly, there is evidence of shared underlying features,
such as altered cognitions, disturbed social and emotional
functioning [36,37]. Additional support for common fac-
tors underlying both affective and psychotic pathology, or
for reciprocal causal influence, comes from longitudinal
studies showing subclinical psychotic experiences predict
not only subsequent onset of psychotic disorders [38] but
also affective disorders, even when psychotic experi-
ences are not considered clinically relevant [39]. The co-
occurrence of subclinical psychotic experiences and major
depressive disorder also predict poorer outcomes [40].
Consequently, comorbidity issues need to be carefully con-
sidered amongst young people at risk for psychosis, as a
potential predictor, moderator, or concurrent outcome.
Limited reporting about implementation of specialised
psychosis related services
Despite the relatively long-standing research emphasis
on psychosis risk identification, and the potential for
early intervention, there have been few published papers
about the implementation and evaluation of associated
specialised services [41-47]. Two Australian services previ-
ously documented are Melbourne’s Personal Assessment
and Crisis Evaluation (PACE) clinic [42,44] and Newcastle’s
Psychological Assistance Service (PAS, initial 2 years) [41].
When identifying individuals at risk, or within the early
stages of a psychotic illness, most services have applied
broadly similar criteria to the PACE clinic [3,42], but often
with an additional focus (e.g., early prodromal and basic
symptoms [45]; multi-element interventions for early
psychosis [47]). Across these services, there have been con-
sistently higher rates of presentations by males (60-70%),
and amongst individuals meeting UHR criteria, attenuated
symptoms have been more prominent. Referrals have typ-
ically been from MH services, with the particular pathways
being largely determined by the health care systems within
which those services operate (e.g., centralised public health
systems in Australia and the United Kingdom, versus spe-
cialised and university clinics elsewhere).
The current study
Although transition rates and the prediction of psychosis
outcomes are still a central focus of research endeavour
[48], there is a growing emphasis on the nature and se-
verity of presenting problems, associated comorbidity, and
both psychosis and non-psychosis outcomes [15,34,40].
Against this backdrop, and the limited publications report-
ing on the implementation of specialised psychosis re-
lated services, it is perhaps timely that we report theinitial findings from our layered service audit (Layer 1:
Baseline profiles).
The current service evaluation study was based on all
presentations to a specialised ‘Psychological Assistance
Service’ (PAS, Newcastle) for young people between service
commencement in 1997 and December 2007; outcome
data (relating to subsequent treatment, service contacts,
admissions, transition to psychosis and comorbidity) were
collected for a further two years, and will largely be the
subject of future papers.
The primary aims of the present paper were threefold:
1) to describe the socio-demographic and clinical char-
acteristics of PAS clients (including their psychosis and
UHR status, previous service contacts, hospitalisation rates,
and diagnostic and comorbidity profiles), and identify key
groups for subsequent comparisons; 2) to document any
service level or data collection factors or changes during
the audit period that could impact on subsequent out-
comes (and need to be considered as potential covariates);
and 3) to examine the clinical and other characteristics of
those clients who received ongoing treatment by PAS, rela-
tive to those who were primarily assessed and referred
elsewhere.
Two problems that beset UHR and associated psychosis
research relate to the identification of relevant comparison
groups and the potential contamination/confounding of
baseline and outcome assessments (e.g., where symptoms
initially identified as transient at baseline actually con-
tinue until the first outcome assessment, and do not
represent a new clinical episode or genuine transition).
Many studies have contrasted UHR and first episode
groups (e.g., [41,49,50]). While this is a valuable compari-
son for assessing underlying characteristics and possible
developmental trajectories, it is less useful for exam-
ining differential conversion rates, since ‘transition to
psychosis’ by those with UHR is essentially being com-
pared with ‘conversion to established psychosis’ (generally
schizophrenia) by those who already have a psychotic dis-
order. It is equally as important to examine subsequent
transition to psychosis and associated characteristics
and comorbidity by those who do not meet either psych-
osis or UHR criteria on initial presentation to services.
By utilising all available service level data (as opposed
to discrete assessments conducted solely for research
purposes), the current study seeks to identify a clearer set
of clinical groups (against which to compare subsequent
clinical and service level outcomes for those classified as
UHR), together with a better separation of baseline and
outcome data.
Methods
The Psychological Assistance Service (PAS)
PAS was established in Newcastle (Australia) in 1997
and provided a community-based specialist service for
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experienced a psychotic or related episode, or who were
potentially at increased risk of developing a psychotic
disorder. Psychosis risk status assessment was bench-
marked against the criteria used by Melbourne’s PACE
clinic [2,44], with PAS using comparable entry criteria
and assessment methods (e.g., for assessing ‘at risk mental
states (ARMS)’). Typically, this comprised a preliminary
risk assessment followed by more intensive assessments
conducted over multiple sessions (among those likely
to be at increased risk, or with complex or unclear
presentations), together with various neuropsychological
and self-report measures [41]. Subsequently, PAS adopted
a shorter assessment procedure that applied to all presen-
tations, which was based on the PACE clinic’s Compre-
hensive Assessment of At Risk Mental States (CAARMS)
[51]. The CAARMS instrument allows several aspects of
risk to be coded, including family history, recent deterior-
ation in functioning (e.g., a drop of 30 GAF points in the
past 12 months), attenuated psychotic symptoms, and
transient self-limited psychotic symptoms of less than one
week duration (BLIPS). All (ARMS-based) assessments
conducted prior to the introduction of the CAARMS
were re-coded to an equivalent format. Approximately
one-fifth of clients received ongoing (medium-term) treat-
ment from PAS, which was provided by a small, multidis-
ciplinary team of clinicians. This included psychiatric
assessment and review, medication (if required), case
management, cognitive behaviour therapy (CBT), family
interviews, and/or other therapeutic interventions, as
appropriate.
Data sources
The data for this audit included both paper based and
electronic clinical records from three different sources:
1) PAS clinical records; 2) community clinical records;
and 3) hospital admission records. These data were
processed separately initially, taking note of service de-
livery dates, and then any duplicate entries or inconsist-
encies were resolved. A PAS referral date was identified
for each client, which was used as the basis for classify-
ing all service occasions (i.e., community presentations
or hospital admissions) into one of five timeframes:
a) more than 2 years pre-PAS; b) up to 2 years pre-
PAS; c) within two months following PAS referral (which
we refer to as the two-month ‘PAS presentation window’);
d) up to 2 years post-PAS (i.e., beyond the presentation
window); and e) more than 2 years post-PAS.
Importantly, ‘baseline’ classification of clients into groups
was based on all available service data up to and including
two months post-PAS presentation. Any recorded psych-
osis episodes with dates before the PAS referral date were
regarded as ‘existing psychosis’ episodes, while those falling
(or assessed) within the PAS presentation window wereregarded as ‘recent psychosis’ episodes. Although the term
‘first episode psychosis’ probably applies to many of the lat-
ter episodes, we have avoided using this term here because
episode onset and frequency were not always assessed
(only by exclusion) and a proportion of the ‘existing epi-
sodes’ would have also been ‘first episode psychosis’.
PAS data (presentations: 1997–2007, +2 years for ongoing
treatment profiles and other outcomes)
Client information was initially translated from paper
based service entry books into an electronic client data-
base, which was subsequently matched against records
from an existing PAS Access database. There were 2206
presentations to PAS during the audit period, 32 of
which were excluded because of insufficient key identifying
data (e.g., name or medical record number, referral or pres-
entation dates). Among the remaining 2174 presentations,
there were 1997 index presentations (by 1178 male and
819 female clients), with 177 repeat presentations (for sep-
arate clinical episodes involving the same clients).
On the basis of their own assessments (including the
CAARMS), and other referral and service information,
PAS initially classified all assessed clients in terms of
their probable psychosis status and, where appropriate,
their UHR status (including UHR subgroup status based
on attenuated psychotic symptoms of recent onset,
BLIPS, and/or trait-state risk factor criteria). The sole
source of UHR status information was the PAS assess-
ments, although (as described below) for the current ana-
lyses final assignment to groups was based on all available
service level data.
Community data (1997–2009)
These data were extracted from two separate community
sources: a) the ‘CROOS database’ (1997–2002), which
was a stand-alone, MH service specific Access database
containing limited client level information, service con-
tacts and diagnoses; and b) the ‘CHIME system’ (2003–
2009), an electronic database which progressively replaced
CROOS from 2002–2003. CHIME is a comprehensive,
community based client electronic record integrating
data from community health and MH services. Service
contacts, diagnostic data, and presenting problems/issues
were initially processed separately; however, duplicate re-
cords and all admissions for persons younger than 12 years
were deleted prior to the data being combined. As individ-
uals varied in the length of time pre- and post-PAS for
which service level data might be available (depending on
their age at PAS presentation, the year in which they first
presented, and the completeness of the relevant data sys-
tems), a common metric was adopted for calculating com-
munity contact rates, namely the number of service
contact days per year (pro-rated for each individual based
on the available data window). Similarly, to facilitate data
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classified into nine common categories (psychosis, depres-
sion, anxiety, substance misuse, personality disorder, other
MH problems, psychosocial issues, physical disorders, and
other non-MH problems); when removing redundant re-
cords (e.g., equivalent diagnostic and problem/issue cat-
egories for the same service contact occasion) and for
other hierarchical assignments, priority was given to diag-
nostic information (i.e., ICD-10 diagnoses) over ‘issues’
based CHIME listings.
Hospital admission records (1993–2009)
These data were extracted from two regional electronic
hospital records systems: HOSPAS (1993–2003) and IPMS
(2004–2009); only admissions from 12 years of age on-
wards were considered. Both systems collected comparable
clinical data in terms of demographic information, length
of stay, service use and diagnoses; any duplicate records
were removed after data aggregation. Diagnoses were also
re-classified into the nine common categories described
above. Likewise, to adjust for variations in data availability
timeframes across individuals, admission rates were calcu-
lated as admission days per year.
Ethics and data access approvals
As noted above, data reported here are from a layered
service audit. Most aspects of this project received an
exemption from formal review by the Hunter New
England (HNE) Human Research Ethics Committee (letter
dated March 25th 2008), being viewed as part of an in-
ternal, low risk, service evaluation. Project layers involving
linkages with other assessments conducted primarily for
research purposes, and/or by research students, received
separate approvals from the same Ethics Committee
(03/12/10/3.16 and 12/11/21/5.06). Access to clinical
records and selected databases within HNE MH services
was approved by the Area Director of MH services, in-
cluding access to PAS records and the CROOS data-
base. Access to regional health databases (e.g., CHIME,
HOSPAS, IPMS) was approved by relevant departmental
managers from within HNE Local Health District. Project
data management and analysis have been undertaken by
the MH-READ unit within HNE MH services, of which
the first three authors (AMC, TJL, KAS) are members.
Allocation to baseline groups
The allocation of PAS clients (N =1997) to baseline clin-
ical groups was hierarchical in nature, with priority
given to any evidence of psychosis in the period up to
and including the two-month PAS presentation window.
This facilitated a more accurate classification of clients
into five groups: Group A – ‘existing psychosis’ prior to
the PAS referral date (based on all available evidence
from community and admission records, PAS referralinformation and assessments); Group B – ‘recent psychosis’,
based on similar information and assessments but with no
evidence of psychosis prior to the referral date (only during
the PAS presentation window); Group C – ‘Ultra-High Risk
(UHR)’ group, based on PAS’s clinical assessment (and
non-membership of groups A or B); Group D – ‘non-
psychosis MH disorders’ group (e.g., depression, anxiety,
substance misuse, personality disorder), based on all
available service level data and assessments (and non-
membership of groups A to C); and Group E – labelled
as ‘uncertain’ (N =250 clients or 12.5%), about whom
limited information was available (but with no basis for
allocation to groups A to D), including individuals deemed
not suitable for full assessment (13.9% of Group E), who
refused assessment (13.4%), who were referred elsewhere
(42.9%), or who had minimal or no contact with PAS
(29.8%). Consequently, Group E was omitted from several
of the analyses (e.g., when socio-demographic or diagnostic
information was required).
Statistical analyses
Microsoft Excel/Access and SPSS statistical software
(Version 17.0; SPSS, Chicago, II, USA) were used for
data processing and analyses. Chi-square tests (for cat-
egorical variables) and analyses of variance (for continu-
ous variables) were used to examine differences between
groups for the demographic variables, diagnostic and co-
morbidity profiles. In addition, community contacts and
admissions were expressed as rates per year for the pur-
poses of describing the data. Univariate and multivariate
(two-step hierarchical) logistic regressions were used to
examine predictors of treatment intensity within PAS.
As a partial control for the number of statistical tests,
the threshold for significance was set at p <0.01.
Results
Sample characteristics
Table 1 reports selected demographic and referral source
information for the PAS clients included in the audit
(N =1997). Overall, 14.5% were classified as having an
‘existing psychosis’ (Group A, N =289), 19.8% as ‘recent
psychosis’ (Group B, N =395), 9.6% as UHR (Group C,
N =191), and 43.7% as ‘non-psychosis MH disorders’
(Group D, N =872); while the remainder (12.5%) were
assigned to the ‘uncertain’ group (Group E, N =250), hav-
ing received minimal assessment and with limited or no
information about previous contacts with health services.
Within the UHR group, 26.2% reported a family history
of psychosis (N =50), 69.1% had attenuated symptoms
(N =132), and 16.2% had experienced BLIPS (N =31).
Overall there were more males (59.0%) who presented
to PAS, with differential profiles across groups (χ2(4) =20.0,
p <0.001), associated with more males in the two psych-
osis groups. While the sample was relatively young, with
Table 1 Baseline characteristics of clients presenting to PAS (N =1997)
Characteristic (%) Overall A: Existing psychosis
(in pre-PAS period)
B: Recent psychosis (during
PAS presentation window)





(N =1997) (N =289) (N =395) (N =191) (N =872) (N =250)
Gender (% males) 59.0 68.5 62.8 57.1 56.3 52.8
Age
Mean (SD) 19.2 (4.5) 21.0 (4.7) 19.6 (3.8) 17.6 (3.0) 18.9 (4.6) 19.1 (5.5)
Less than 18 years (%) 55.6 36.0 52.7 70.7 59.2 59.2
Referral source
Self or family 18.4 5.9 12.2 16.8 23.1 28.0
Community MH 13.5 21.1 20.3 8.9 10.7 7.2
Hospital 14.8 42.9 15.4 6.3 10.1 4.4
GP 2.7 0.7 3.5 3.1 3.2 1.6
Other services 17.5 5.9 13.7 17.8 23.2 17.2
Unknown 33.0 23.5 34.9 47.1 29.8 41.6
Other demographic
information available




(N =936) (N =134) (N =284) (N =129) (N =368)
Marital status
Single 92.9 92.5 92.6 96.9 92.0
Educational level
High school only 86.8 86.4 84.4 89.1 87.9
Accommodation
Live with family 77.9 81.2 78.9 81.3 74.9
Live in house/flat 16.3 12.8 16.5 15.6 17.6
Short term 5.8 6.0 4.6 3.1 7.5
Employment status
Employed 21.1 24.6 18.4 23.0 21.2
Unemployed 43.8 57.5 46.3 27.8 42.4
Student 35.2 17.9 35.3 49.2 36.4
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ences between groups (F(4, 1997) =19.4, p <0.001), with the
UHR group being the youngest (averaging 17.6 years). Re-
ferral source differences (χ2(20) =369.2, p <0.001) followed a
consistent pattern, with 42.9% of clients with existing
psychosis referred by hospitals, 20.3% of clients with re-
cent psychosis referred by community MH teams, and
higher rates of self-referrals across the other groups
(16.8% - 28.0%).
The lower portion of Table 1 summarises the other
demographic data available for Groups A to D. There
were no significant group differences for marital status,
accommodation or employment, with the majority of cli-
ents being single (92.9%), living with family (77.9%), and
having completed high school (86.6%). Employment dif-
ferences (χ2(6) =34.3, p <0.001) reflected the age profiles,
with 49.2% of the UHR group being students.Psychosis profiles
Table 2 presents a breakdown of the psychosis related
diagnostic profiles for the two psychosis groups, with
individuals potentially allocated to multiple categories
using all available information about psychosis episodes.
The first seven categories in Table 2 are based on ICD-
10 diagnoses (from hospital or community records),
while the last three are based on psychosis related prob-
lems or issues identified in PAS clinical notes or CHIME
electronic clinical records. Overall, the vast majority
(92.7%) of those within the existing psychosis group had
at least one formal psychosis diagnosis, including 46.7%
with a schizophrenia diagnosis, 33.2% with an ‘unspeci-
fied nonorganic psychotic disorder’, 21.8% with an ‘acute
or transient psychotic disorder’, and 20.4% with bipolar
disorder (including mania); additionally, 38.8% also had
at least one psychosis problem/issue identified in other







Formal ICD-10 diagnoses [92.7] [63.8]




3. Acute or transient psychotic
disorder
21.8 22.0
4. Schizoaffective disorder 6.9 1.7









Other clinical records (e.g., CHIME) [38.8] [49.9]
8. Schizophrenia (problem/issue) 11.1 18.9




Note: Tabled values are the percentage of each group with any evidence of
that diagnosis/problem during the time period, based on all available
assessments (A: 698; B: 581), with assignments not mutually exclusive;
aggregate psychosis rates for formal diagnoses and other clinical records are
shown in square brackets; CHIME, electronic clinical record system used by
community based services.
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equivalent categories had generally lower rates, with
63.8% having a formal psychosis diagnosis (including
24.5% with schizophrenia and 7.1% with bipolar disorder);
moreover, half (49.9%) of the recent psychosis group also
had at least one psychosis problem/issue identified in other
records.
To further examine within-psychosis comorbidity, we
pooled the formal ICD-10 diagnoses and the correspond-
ing problems/issues identified in the other clinical records.
For example, within the existing psychosis group, 52.9%
(N =153) were identified as having schizophrenia and
23.2% (N =67) with bipolar disorder, with only a small
overlap between these conditions (N =17, or 5.9%). Simi-
larly, within the recent psychosis group, the corresponding
aggregated rates were: schizophrenia, 41.5% (N =164); bi-
polar disorder, 15.7% (N =62); and overlap, 1.5% (N =6).
Thus, the within-psychosis overlap between the schizo-
phrenia and bipolar disorder categories was minimal.
In view of the ongoing debate within the clinical and
research literature about what constitutes the prodromal
phase of illness and transition to psychosis, we also ex-
amined the timing of psychosis episodes among clients
allocated to the recent psychosis group. With respect to
the first reported episodes within the PAS presentation
window (N =395), half (57%) were identified from PAS
clinical information, 9.9% came from inpatient records,and 33.2% from community records. Among the subset
with detailed service delivery or assessment date infor-
mation (N =298, 75.4%), the average time interval was
13.2 days post-PAS referral (with a median of 9 days);
two-thirds (66.4%) of these assessments occurred within
two weeks of PAS referral, while only 12.5% occurred
more than four weeks after the referral date. The timing
of these episodes (based solely on assessment dates) sug-
gests that for the majority of clients the psychosis symp-
toms that were detected were probably also present at
the PAS referral date and initial assessment rather than
developing subsequently.
Comorbidity profiles
As shown in Table 3, PAS clients had high levels of
comorbidity across the various ‘baseline’ assessments
and service presentations. Overall, there were significant
group differences for every condition, except personality
disorder. The highest levels of depression (62.3%) and
anxiety (42.9%) were identified among the UHR group,
while substance misuse (52.9%) and psychosocial issues
(70.2%) were particularly notable among the existing
psychosis group. The lower rate of substance misuse
problems within the UHR group (6.8%) is not surprising,
since 70.7% were under the age of 18 years at PAS pres-
entation. Conversely, the relatively high rates of physical
disorders (37.7%) and other non-MH problems (25.6%)
among the existing psychosis group are noteworthy,
considering that their mean age was only 21 years.
Service utilisation
Table 4 reports community contacts and hospital admis-
sion profiles for the five clinical groups. The first row of
the table shows the estimated availability period for
medical records, on which community contact and hos-
pital admission rates were based; which, once again, par-
tially reflects differences in the mean age across groups
and variations across PAS presentation years. Overall,
the PAS clients (N =1997) had 6.3 years of baseline data
available, amounting to 9618 community contacts, or
the equivalent of approximately one contact per client
per year with any adult MH service. These rates are
somewhat inflated by the high number of contacts within
the short, two-month presentation window (which aver-
aged over one contact per month). However, comparisons
across groups are appropriate within the same metric;
more generally, service contact rates are often inflated
when sample selection is based on an index event (in this
case, presentation to PAS). Those in the existing psychosis
group had the highest aggregate contact rates per client
per year (1.25), while the UHR and recent psychosis
groups had the highest level of PAS contact during the
presentation window (averaging 3.16 and 2.96 contacts,
respectively). In relation to hospital admissions, 84.1% of
Table 3 Baseline comorbidity profiles for PAS clients (N =1747)











(Groups A to D)
(N =1747) (N =289) (N =395) (N =191) (N =872)
Depression 43.8 36.7 49.6 62.3 39.4 χ2(3) =44.7**
Anxiety 25.1 21.5 34.2 42.9 18.3 χ2(3) =72.7**
Substance misuse 26.5 52.9 37.0 6.8 17.3 χ2(3) =201.7**
Personality disorder 17.1 16.6 16.2 20.9 16.7 χ2(3) =2.3
Other MH problems^ 67.3 68.9 55.7 67.5 72.0 χ2(3) =33.3**
Psychosocial issues 40.4 70.2 39.2 41.9 30.7 χ2(3) =141.1**
Physical disorders 14.0 37.7 13.2 6.3 8.3 χ2(3) =168.3**
Other Non-MH problems 15.1 25.6 14.2 7.3 13.8 χ2(3) =35.3**
Note: ^Within this category, the proportionate breakdown of conditions was: 70.1% attentional problems, 8.9% service related problems, 6.2% adjustment
disorders, 5.6% childhood disorders, 1.6% intellectual disability, and 7.6% other problems (other behavioural and MH disorders, cognitive related problems,
neurological disorders). Statistical significance: *p <0.01, **p <0.001.
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sion, averaging 3.39 admission days per client per year,
well above the other groups.
Figure 1 illustrates the pattern of presentations to PAS
across the audit period. At least two trends are worthy
of comment. Firstly, there was an overall reduction in
the number of presentations from 2004 onwards, which
coincided with service relocation, staffing alterations, andTable 4 Baseline community contacts and admission profiles
Overall A: Existing
psychosis
(N =1997) (N =289)
Estimated availability of medical records - mean
(median) years
6.3 (5.9) 7.7 (7.5)
Community contacts
Total contacts 9618 2499
Average contact days per year (excluding
presentation window)
0.98 (0.31) 1.25 (0.57)
Average number of PAS contacts within
presentation window
2.25 2.32
All admissions (Min. age 12 years)
Total admissions 1788 674
Total beddays 12748 6739
Any admission (%) 40.7 85.5
Average admission days per year 1.08 3.62
MH admissions
Total admissions 1090 537
Total beddays 10787 6343
Any admission (%) 28.2 84.1
Average admission days per year 0.91 3.39
Note: The relevant timeframe includes the pre-PAS period plus the two-month PAS
admissions from the age of 12 years); average contact/admission days per year incl
are largely limited to PAS.changes in referral and assessment procedures. Secondly,
over time there was a proportionate reduction in the
number of clients assigned to the uncertain group, which
occurred for a mixture of reasons: improved access to
electronic records; improvements in clinical documenta-
tion and assessment procedures (including the change to
a more uniform, CAARMS based assessment); and the
simple increased volume of potential pre-PAS recordsby PAS clients (N =1997)
B: Recent
psychosis





(N =395) (N =191) (N =872) (N =250)
6.6 (6.1) 5.4 (5.1) 6.2 (5.8) 5.5 (5.4)
2253 980 3631 255
0.99 (0.28) 1.38 (0.37) 0.99 (0.31) 0.33 (0.00)
2.96 3.16 2.07 1.01
357 87 601 69
3042 297 2452 218
45.1 26.7 33.1 18.8
1.48 0.30 0.48 0.17
210 40 303 0
2438 214 1792 -
33.4 12.0 19.0 0.0
1.23 0.22 0.35 -
presentation window (i.e., presentations to youth and adult services, and


































Year of presentation to PAS
Existing psychosis
Recent psychosis
Ultra High Risk (UHR)
Non psychosis MH disorders
Uncertain
Figure 1 Pattern of presentations to PAS by year.
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for the available electronic databases – 1993 for hospital
records and 1997 for community records).
Potential confounders
Based on the service changes noted above, the various
data collection methods and changes across the audit
period, and the preliminary analyses, a small set of six
potential covariates was selected (that could impact on
subsequent outcomes): gender (male: N =1178; female:
N =819); age group (under 18 years: N =1111; 18+ years:
N =886); service year block (1997–2003: N =1369; 2004–
2007: N =628); PAS treatment status (assessment only:
N =1593; some ongoing treatment: N =404); and the
length of potential data availability windows per client
(pre-PAS plus presentation window: mean =6.32, SD =2.82,
range =0.17 to 14.93 years; post-PAS: mean =7.40,
SD =2.86, range =1.86 to 12.76 years).
PAS treatment status
The uncertain group (Group E) was excluded from the
analysis of PAS treatment status, due to the absence of
information about comorbidity, leaving N =1747 clients
in this analysis. During the first 26 months after PAS re-
ferral (i.e., the presentation window plus 2 years), the
average number of PAS contacts was 4.86 (SD =6.89,
median =2, range 1 to 64); three-quarters (76.4%) of which
occurred within 8 months of PAS referral. For conveni-
ence, we identified two sub-groups: those who primarily
received an assessment (i.e., with 6 or fewer contacts;
N =1342, mean =2.11, median =1 contact); and those
receiving some ongoing treatment (N =404, or 23.1%,
mean =13.98, median =10 contacts). The outcome variablefor the logistic regression analyses was treatment status
(0: assessment only vs. 1: ongoing treatment), the other five
potential confounders listed above were included as covari-
ates in the multivariate analysis (at step 1), and there were
nine main predictors (at step 2): clinical group, with non-
psychosis MH disorders (Group D) as the reference group,
and the eight baseline comorbidity variables identified in
Table 3 (categorized as 0: absent vs. 1: present).
As shown in Table 5, relative to those with non-
psychosis MH disorders (12.3% receiving PAS treatment),
there were significantly higher (p <0.001) rates of on-
going treatment among the existing psychosis (25.6%,
Adjusted Odds Ratio, AOR =3.40), recent psychosis (33.4%,
AOR =5.80) and UHR groups (47.6%, AOR =9.57). In
addition, higher ongoing treatment rates were experienced
by those with depression (28.5%, AOR =1.54, p =0.002) or
anxiety (33.7%, AOR =1.62, p =0.002), and lower rates by
those with substance misuse (17.3%, AOR =0.53). There
was also a tendency for those with other comorbid
MH problems to have higher treatment rates (28.1%,
AOR =1.59, p =0.010). Psychosocial issues, physical dis-
orders and other non-MH problems were not signifi-
cantly associated with treatment by PAS. In short, PAS
was more likely to provide treatment to those at risk for
or experiencing psychosis and to those with greater dis-
tress (e.g., anxiety/depression) or dysfunction (e.g., atten-
tional problems), a treatment pattern that is consistent
with the service’s broad specialisation.
Discussion
Who presented to PAS
PAS in Newcastle and the PACE outpatient clinic in
Melbourne [2] were deliberately established with generic
Table 5 Relationships between baseline client characteristics and receipt of ongoing treatment by PAS (N =1747)




99% CI Adjusted Odds
Ratio (AOR)
99% CI
Gender: Male 23.2 (vs. 23.0) 0.98 (0.73, 1.32) 0.89 (0.64, 1.26)
Age: Less than 18 years 26.1 (vs. 19.5) 1.45** (1.07, 1.96) 1.05 (0.59, 1.87)
Diagnostic group
Existing psychosis 25.6 2.46** (1.59, 3.81) 3.40** (2.11, 5.48)
Recent psychosis 33.4 3.58** (2.44, 5.25) 5.80** (3.75, 8.96)
Ultra high risk 47.6 6.50** (4.11, 10.28) 9.57** (5.66, 16.18)
Non-psychosis MH disorders 12.3 (ref) 1.00 1.00
Comorbid condition¥
Depression 28.5 (vs. 18.9) 1.70** (1.27, 2.28) 1.54* (1.07, 2.22)
Anxiety 33.7 (vs. 19.6) 2.09** (1.52, 2.86) 1.62* (1.09, 2.39)
Substance misuse 17.3 (vs. 25.2) 0.61** (0.43, 0.88) 0.53** (0.33, 0.84)
Personality disorder 23.5 (vs. 23.1) 1.02 (0.69, 1.50) 0.87 (0.54, 1.39)
Other MH problems^ 28.1 (vs. 12.8) 2.67** (1.85, 3.84) 1.59* (1.00, 2.54)
Psychosocial issues 22.1 (vs. 23.8) 0.90 (0.67, 1.22) 0.81 (0.54, 1.21)
Physical disorders 29.0 (vs. 22.2) 1.43 (0.96, 2.12) 1.20 (0.70, 2.03)
Other Non-MH problems 22.3 (vs. 23.3) 0.94 (0.62, 1.43) 0.66 (0.39, 1.11)
Note: Significance tests were based on Wald statistics: *p <0.01, **p <0.001; adjusted analyses controlled for all tabled variables, plus service year block and
available data windows (pre-PAS ). ¥Includes history of comorbid conditions or concurrent conditions present at the time of assessment. ^See Table 3 for
further details.
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young people experiencing a range of difficulties to at-
tend. More recently, similar services around the world
(and those linked to research programs, in particular)
have tended to use more selective referral networks and
screening processes to identify a narrower range of
potential clients. For the problems that comprised the
primary PAS target groups, the yield across the audit
period was considered reasonable (existing/recent psych-
osis yield: 684/1997 or 34.3%; UHR yield: 191/1997 or
9.6%). However, compared to the other psychosis-related
services described earlier, PAS had a much higher per-
centage of ostensibly non-psychosis related presentations
(872/1997 or 43.7%), largely reflecting differences in
health care systems and referral/assessment processes;
which, on the positive side, provided a naturalistic com-
parison group for examining future transition to psychosis.
PAS also developed a local reputation for undertaking
comprehensive diagnostic assessments, which may have
accounted for some referrals of complex cases (with or
without a possible psychosis).
There was a higher overall percentage of males (59%)
presenting to PAS, which is consistent with similar ser-
vices elsewhere (e.g., [45]), and the majority of clients
(55.6%) were less than 18 years of age. Two-thirds of cli-
ents (68.5%) with an existing psychosis were male, and
they also experienced the highest rates of comorbid sub-
stance misuse (52.9%), psychosocial (70.2%), physicalhealth (37.7%) and other non-MH (25.6%) problems, and
MH admissions (84.1%); these findings are consistent with
the profiles highlighted in recent Australian National MH
Report Cards [52] for individuals with an established ser-
ious mental illness. With respect to diagnosis, almost half
(46.7%) of those with existing psychosis received a schizo-
phrenia diagnosis, compared with one-quarter (24.5%) of
the recent psychosis group; this pattern probably reflects a
mixture of illness stage differences (e.g., evidenced by dif-
ferent comorbidity profiles – see Table 3) and data source
differences (e.g., diagnostic/assessment practice differences
associated with variations in the rates of previous hospital
admissions and subsequent referrals – see Tables 1 and 4).
Notwithstanding, subsequent conversion rates to schizo-
phrenia amongst the other members of the recent psych-
osis group (i.e., not presently identified as having a
schizophrenia diagnosis or problem) could be a worthwhile
additional component in future analyses.
Among the UHR group, half of whom (49.2%) were
students, there were high rates of attenuated psych-
otic symptoms (69.1%), in accord with previous studies
(e.g., [45,53]); likewise, the BLIPS rate (16.2%) was ap-
proximately midway between the older and more recent
naturalistic studies reviewed by Simon and colleagues [9].
There were also relatively high rates of comorbid depres-
sion (62.3%), anxiety (42.9%), and attentional and related
problems (67.5%), which may have precipitated service
presentation at that time; indeed, the majority of this
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with MH services were with PAS. Comorbidity profiles
among the UHR group were also generally comparable to
those reported elsewhere [32-34], with the low rate of
substance misuse problems (6.8%) consistent with their
mean age of 17.6 years. While such problems typically go
beyond UHR criteria, they are the focus of everyday clin-
ical attention and contribute to the reasons for clients
seeing help [5]. Ongoing monitoring of risk, and any
signs of deterioration, can be undertaken while simultan-
eously addressing these presenting problems [5].
Reductions in annual presentations to PAS and in the
percentages of clients assigned to the ‘uncertain’ cat-
egory (see Figure 1) are reflective of service, assessment,
and data accessibility changes over time, and not an
underlying change in the relevant regional population.
However, such changes, together with the observed
baseline differences between the clinical groups in socio-
demographic characteristics (Table 1), comorbidity profiles
(Table 3), and involvement in ongoing PAS treatment
(Table 5), highlight the fact that these potential con-
founders need to be carefully taken into account in future
analyses of PAS outcomes (such as comparisons between
groups in transition rates and subsequent comorbidity and
service utilisation).
Who received treatment
Several factors are likely to have contributed to PAS
treatment patterns. Firstly, the service’s major focus on
those at risk for or experiencing psychosis is reflected
in the higher percentages receiving ongoing treatment
within the UHR (47.6%) and recent psychosis (33.4%)
groups. Secondly, the observed associations between
higher ongoing treatment rates and comorbid depression/
anxiety and other MH problems, but not substance mis-
use, may partially reflect the nature of the psychological
treatments likely to be offered (such as CBT), relative
to other specialised services to which PAS could refer
(e.g., substance misuse services), together with specific
concerns for clients experiencing greater distress or dys-
function at presentation.
Those receiving ongoing PAS treatment averaged ap-
proximately one session every 8 weeks during the first two
years post-presentation; however, in practice, more inten-
sive treatment was delivered during the first six months,
followed by periodic review. Having contact with PAS as
part of an early intervention strategy might have been
beneficial to these clients, especially with respect to educa-
tion about mental illness, reducing stigma, or providing
diagnostic information. In any event, on average, clients
who received ongoing PAS treatment appear to have had
either more complex or more symptomatic presentations.
As noted earlier, in some instances clients were seen by
PAS primarily for the clarification of diagnostic issues,which would be expected to occur more frequently among
those displaying comorbidity. Further, research evidence
suggests that symptoms of depression and anxiety are
present in the majority of clients with schizophrenia, and
perhaps these symptoms could be used to identify distinct
clinical subgroups among those with psychosis [40]. More-
over, recent studies have shown that anxiety disorders,
particularly social anxiety, are highly prevalent and con-
tribute significantly to a reduction in quality of life,
particularly social isolation, feelings of helplessness, and
lower self-esteem [31,35].
Future directions
The current paper is largely descriptive in nature and
we acknowledge that it is difficult to directly compare
psychosis related services operating in different coun-
tries and within different health care models, which may
partially account for the limited number of published pa-
pers documenting the implementation and evaluation of
such services. Notwithstanding, we encourage others to
undertake similar comprehensive service audits, primar-
ily because they assist in the review and refinement of
services, but also because they stimulate consideration
and investigation of related research, treatment and
translational issues. Such evaluations also need to both
inform and be mindful of strategic changes in health
service delivery for young people that are currently
being undertaken in many countries (e.g., eHealth based
initiatives). In Australia, for example, a range of ‘head-
space centres’ have now been established, designed as
“highly accessible, youth-friendly, integrated service hubs
that provide evidence-based interventions and support to
young people aged 12–25 years around their mental
health, health and wellbeing needs” [54].
It may be an obvious methodological observation, but
it is worth noting again that different patterns of com-
parisons between clinical groups, ideally across mul-
tiple time points, can provide different insights about the
underlying problems. So, for example, comparisons within
UHR groups between those experiencing and those not
experiencing a certain outcome, such as transition to
psychosis, or UHR remission [9], can aid our understand-
ing of potential mediators and/or contextual or environ-
mental factors at play; while comparisons between UHR
and first episode groups can potentially help to identify
some of the prerequisite conditions or early changes as-
sociated with the disorder of interest. In the current ser-
vice evaluation project, there is a further opportunity to
utilise a relatively novel comparison group, those with
non-psychotic MH disorders (and non-UHR) at baseline,
the largest subgroup presenting to PAS. This will enable
us to explore questions in future papers such as the fol-
lowing: do UHR individuals have differential psychosis
transition rates, or experience different comorbidity or
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demographic characteristics who presented to the same
services during the same time period, but amongst whom
neither psychosis nor associated risk was evident?
Strengths and limitations
While the current dataset provides a basis for comparing
several groups of young clients, who are presumably at
various illness stages, it nevertheless draws from initial
presentations to a single Australian psychosis related
service. There are both advantages and disadvantages to
using real-world service level data, as opposed to data
collected within a formal research framework, which
largely boil down to breadth versus depth issues. Service
level data is particularly useful for accessing accurate in-
formation about service contacts, admissions, presenting
problems, and so on, over extended periods of time, rela-
tive to self-reported research measures. Larger sample
sizes, a lower likelihood of selection biases (e.g., by consid-
ering all presentations), and minimal exclusion criteria
(e.g., retention of those not meeting UHR criteria), are
inherent strengths of service level data.
However, the quality and availability of service level
data can be variable. In our case, we used all available
baseline service level data for a period exceeding a dec-
ade; moreover, for each individual, we essentially looked
beyond a single assessment timepoint to a service based
window in time (for many clients, from approximately
12+ years of age to service presentation). On the other
hand, research studies typically use standardised scales
and structured assessments to more comprehensively
assess clinical characteristics, risk factors, treatment fi-
delity, and selected outcomes. For example, within the
current project, one of the obvious limitations was the
lack of access to detailed comparative information about
current symptomatology, illness chronicity, specific treat-
ments received, or medication usage.
Conclusions
We have successfully extracted and processed a large
amount of service level data (from multiple sources)
relating to presentations over a decade to a specialised
service for young people experiencing or at increased
risk for psychosis. This has facilitated the identification
of two broad groups – those who have already experi-
enced at least one episode of psychosis (N =684, sub-
categorised as existing or recent psychosis) and those
without any such episodes, but who vary in their assessed
levels of risk for psychosis (N =1313, sub-categorised as
UHR, non-psychosis MH disorders, or uncertain). Ob-
served differences between these groups were largely
consistent with expectations based on the research litera-
ture (e.g., a high percentage of males; moderate to
high levels of comorbidity, especially amongst those withexisting psychosis; and high rates of attenuated psychotic
symptoms, depression and anxiety among the UHR group).
Unlike other specialised psychosis-related services, a sub-
stantial percentage of PAS presentations displayed neither
a psychotic disorder nor an increased risk. It is anticipated
that this sub-group will provide a valuable reference point
for future analyses, against which to contrast the health
trajectories of the UHR and recent psychosis groups in
particular.
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